Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The million dollar question is what it means to common shareholders if they do.
https://www.sec.gov/info/smallbus/pnealis.pdf
It’s in the agreement
https://www.sec.gov/Archives/edgar/data/1403570/000149315221002306/ex10-1.htm
Sorry don’t have time at moment to pull quote
If I read it correct, they get funding for $15 million for the 140m shares and difference that gives them 51%
Funny guy, for once! ;)
Thanks. Lol! It’s been a long ride. We’re all worn out.
I took arms over the share structure that involved special shares, not common. That was a long time ago without revenue.
We all get tired of waiting at some point. ;)
We all profit based on my calculations. Just how much depends on future developments from Pasaca, Innova, and QMC.
I believe it's $15 million for 51% of company, plus guaranteed revenue of
It’s getting smaller as people have been eating away at the initial 1 million plus ask.
Quick logical question, $230 million. So how many tests is that at $30 per test? Let's assume they struck a deal for $10 or $20 per test.
https://www.prevention.com/health/a34988733/ellume-at-home-covid-19-test-facts/
That would be 11.5 to 23 million tests. If used twice weekly, that's only about 6 to 11.5 million people getting tested for one week.
I see plenty of market potential left for Innova.
Thanks for providing a clarification.
By your clarification, I see green light tests, in my company’s case, being PCR tests for those that come in contact with those infected. A negative PCR test allows the individual to return to the office. Although, I’m not confident the timing of testing isn’t allowing some to be missed.
Well, clearly a misunderstanding as I didn’t once mention QMC HealthID. I was talking about LFT.
But I know where your views lie with regard to the app, crystal clear!
No, I made a clear argument where a LFT would be better than status quo, temperature check. I’ve not said that they were green light tests. I asked for a clear explanation as two what red or green really means because in my business I think the temperature check is both a red and green screening item since our teams still work on top of each other with masks, but I’m not clear on how people are defining the two terms.
Guess I’m confused about red light or green light.
Yes, if they run a temperature we go home.
I guess red or green depends on the ongoing precautions still being followed after testing negative.
I kind of consider the temptation check both a red and green light. Red to go home if you have temperature and green to work around others if you don’t.
I don’t consider it apples and oranges. The temperature check is being considered a green light for work places.
Yes in doors appears to be a large contributor to transmission.
Our construction is mostly in doors commercial skyscraper builds and tenant upgrades.
I would prefer that people were taking a test as compared to a temperature check to give a green light. The test is way more accurate at diagnosing a positive case than temperature check.
Our construction teams and office staff are completely relying on a temperature test for green light to work at the location. This is how it is in the construction industry in my area. I’m not sure how other industries are handling screening.
This approach is a major reason this virus is still spreading so rapidly.
Looks like no change for 3 months (since 10/1) per your post.
Thanks again for keeping track of these numbers.
Rhetorical question, I wonder how they are not still issuing shares to cover operational costs?
Looks like no change for at least a couple of months based on your December post.
I wonder how many months without a change. I guess I can search the posts and find November and October info since you or someone else has kept us posted almost monthly.
By the way, thanks for posting the info.
I’m sure not all setups are the same.
The enterprise apps that I’ve dealt with at several companies also provided network and data security functions. All of them installed from the enterprise app, not directly from the App Store.
Very good question and I wish we knew.
Regardless of what the discussion board has discussed, it doesn't negate that QMC and Innova have emphasized the individual company usage potential in PRs. I do recall a few people may have tried to point out the enterprise usage.
July 28, 2020 QMC PR
Some have continued to flaunt the 10+ and 50+ downloads number from Google Play for months.
So I take that as those individuals taking a position on usage.
But, I agree about usage from companies. We don’t have a clue and Innova doesn’t have to release info on contracts as a private company so I don’t think we’ll see anything from them about it. We’re stuck waiting to see if QMC yields revenue from the partnership with Innova. And the wait continues! :(
Does everyone realize that downloads for enterprise applications are downloaded via a different mechanism?
I have over 6 mobile apps for the software that I use for our company’s business.
All of my company's mobile apps are installed via an app called Microsoft Intune Company Portal. They are not downloaded from the App Stores.
If any companies are using QMC HealthID as a company platform, they are likely installing it for their employees via their enterprise application. We have no real clue as to the number of organizations that could be using QMC HealthID at this moment.
Yet, we saw a spike to $0.44 on speculation of QMC prototype reactor production capacity and potential sales in 2014.
Your opinion is just that, your opinion. Many investors do invest on speculation or potential they see by connecting of the dots to make their own picture of how they see things developing. You don’t see the picture that I or others see.
To each their own. You are clearly saying there isn’t much reason other than insider trading for the current share price rise, I disagree.
Squires stated in a trial during testimony that they were involved in test kits and HealthID.
That info along with countless marketing campaigns via company partner websites indicate that QMC may have a portion of sales with Innova. The question is not if QMC is involved, but how are they involved and does it actually correlate to revenue and, if so, how much revenue.
I should have read your next post, lol, because you pretty much said what I replied as being an possible cause. ;)
What because people can’t make a calculated risk decision based on all the info from the trial, media, partnerships, job postings, etc.?
For some there might be more than enough data to think there’s a reason for all the new job postings and partner news. I mean this is what the common investor has to evaluate when making a decision to invest right?
Then again, this stock has seen many ups and downs over the years that this could be just another one of those, but only time will tell.
I don’t know. Per recent numbers, QMC is about out of authorized shares. Since that’s the case and I wouldn’t personally work for just stock for the positions being filled, I’d have to consider other means to pay for more staffing or why they need more staffing. But I’ll leave that deduction to your very capable mind.
I noticed 4 new job posts in the past 2 weeks on Indeed: in house counsel, production chemist, Senior Dev Ops Engineer, and Sales Manager. Here’s the DevOps Engineer job posting.
Full Job Description
As a Senior DevOps Engineer with QDX HealthID, you will need to closely collaborate with the development, product, and quality teams to ensure that our product is delivered reliably, predictably, securely, and at world-class scale. You will need to be quick on your feet, adaptable, and ready to learn, as well as willing to teach and mentor the other DevOps Engineers, Development teams, and other stakeholders.
Responsibilities
Automate the building, testing, deployment, monitoring, and operation of our product and the cloud-native infrastructure it runs on, across global deployments on multiple cloud platforms
Scale infrastructure to meet rapidly increasing demand
Advise, mentor, and assist the development and testing teams to help them build better CI/CD and automated testing processes and cultivate their ownership of those systems.
Implement, maintain, and test a disaster recovery plan
Continuously review, assess, and improve our security and compliance at every point in the software lifecycle
Build out and manage our monitoring, logging, and alerting systems, and document and automate runbooks to guide incident response
Participate in our on-call rotations and respond to incidents, and continuously improve that process
Define, measure, track, and improve key metrics and service level objectives
Document everything
Requirements
5-10 years of software development operations experience in a large-scale SaaS context
Strong knowledge of cloud infrastructure and operations, AWS or Azure preferred
Solid experience with Docker and Kubernetes development and administration in a production scenario
Strong experience with Unix/Linux, Bash, and deploying Java (Spring Boot) applications
Experience deploying and managing databases like PostgreSQL (RDS/Aurora)
A passion for building low cycle-time CI/CD pipelines in a cloud native environment and working with development teams to drive their ownership of those systems
Experience building, extending, and maintaining monitoring and observability solutions for cloud-based products
Dedication to ruthlessly automating away toil and developing tools to make life easier for operations, development, QA, and other stakeholders
Experience designing and implementing infrastructure as code using tools like terraform
Familiarity with Atlassian ecosystem tools like Jira, Opsgenie, and Bitbucket Pipelines
Healthcare industry experience or Blockchain experience a plus
Additional:
Be eligible to work in the USA
You must bring your I-9 documentation with you on your first day of work.
Compensation: Annual salary, paid leave, health insurance, stock options
Job Type: Full-time
Pay: $120,000.00 - $150,000.00 per year
Benefits:
Health insurance
Paid time off
Schedule:
Monday to Friday
COVID-19 considerations:
We are involved in Covid 19 test kits and have developed QDX HealthID, a health passport application.
https://www.indeed.com/m/viewjob?jk=ee53bd82d5dc1534&advn=7365276179558410&adid=361493290&ad=-6NYlbfkN0Bc0MA2hw2FkDg2A_09XhCf4mrWcKz17n4AJMiBzVFUxM_oRwe04USfP05eg2iSy0O963TdlC1goEytHVtVrvIRmdIu-N5Gys1-uL6sHnu3DnKlItpt3fMrwXWt5bWAZLvAMrQBxRpGzTb8yN53tzlEODhE6ubohndTJtuvYfS7D_zgVNWb_exeCTpmMtmtHsRb8v9Jb0Rg27fnVHEWRmdvyNUYyd5QrVNpX07iUt0ub-Hspp8UbP8_0NCeRL4iShE6xyp2itAL8pbelPi7qtv2eF79KMl753NewwupsjHyJN1qDxEm_8ti-TrRE1HVFK1hVi_dxR7tdpkgROAbvtNVfXUrkZiOVEc%3D&from=hp&tk=1ens34okfs9t5800
My apologies if I misunderstood your thinking in your post. I’ve been reading for weeks and when you see arguments in the articles about accuracy they seem to all just want to complain about the fact that some will be missed instead of focusing on the fact additional testing can help reduce transmission rate.
The current PCR testing is way to slow, 4-7 days on average to get results, to lower transmission rate especially with an estimated 40% of people being asymptomatic. So even if some may argue correctly that a negative test may give some false security, we shouldn’t disregard that it clearly could help drive down transmission rate, which hasn’t been accomplished successfully except for small periods of time. Those tested should still exercise social distancing and mask wearing.
Here’s what I don’t get about anyone against adding more testing regardless of accuracy or how many are missed.
So you have 5 people that enter a place infected with Covid-19. What is the transmission rate for those who come in contact with these 5 assuming people come in contact with at least one infected?
Now you have 5 people that enter a place and only 2 of 5 are infected, what is the transmission rate for those who come in contact with these people assuming they don’t some don’t come in contact with the 3 infected?
Does testing even if cases are missed help to reduce the transmission rate? The math would simply say yes. Do people just assume they don’t have to take other precautions since they’ve been tested? The guidance to them should be “no” since you can still come in contact and contract it after being tested. The goal should be to reduce transmission rate and then you can start to open things back up.
Who says the market doesn’t care? Didn’t the volume dry up the last couple days. Are investors that were selling or the buyers just waiting for some validation of the tie between QMC and the Innova order in UK? We can only speculate at this point. I know I’m waiting on some validation.
Concur with calculation, but I think it’s pounds. The website has £138M on award summary page and USD138M on the award detail page.
It’s a British entity and if you look at other nearby awards they’re all in pounds. Could be a typo, maybe not.
Clearly you didn’t read the case filings from Florida case. Those were public. I assume they mirrored Kansas. The claims were laid out and some of us weren’t relying on QMC to state claims from the case.
I didn’t catch where the trial was deemed not jury. Just that the jury trial was canceled for August and then reschedule for trial now.
If you recall, the auditor resigned. QMC didn’t fire them. The stipulations in the agreement said that QMC had to consult L2 if they wanted to change auditors. The way I see it, they were forced by the resignation, therefore they didn’t need L2s permission, but we’ll see what the jury says in a few days.
52 week range bottomed at .0115
Lol! My checkbook has been in hand several times. Just not for 2 years.
False or misleading, not from I. Did the company ever publicly say they were out of testing? Just because they released it on Google Play and Apple Store doesn’t mean it was ready for customers. Others maybe spinning it that way, but I don’t recall a press release stating as such.
Maybe if some of you actually engaged the company in the right way, they’d respond to you.
I can confirm that I purchased the app on iOS and ran into a few bugs with the registration. I relayed my issues to the company and a rep contacted me for more details. I was told that they are still in testing even though it’s a live app on Google and Apple.
By the way, where we they getting the funds to pay company’s to be partners?
You say last ditch effort, yet big pharma like Abbott seems to disagree since they are rolling out a similar, howbeit likely more personal info sharing, app as part of their new antigen test as stated in news last week.
You can be upset with QMC’s lack of revenue and transparency, but other companies seem to be validating their idea as legit. Again as I said, it comes down to whether they penetrate the market somewhere in the world.